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Background: Compounds that either inhibit or induce 
an estrogen response in vi00 are important as potential 
drugs and biochemical tools. Non-steroidal stilbene analogs 
such as tamoxifen are known to function as both estrogen 
agonists and antagonists depending upon the analog 
structure. This family of compounds is amenable to 
parallel-manifold synthesis because stilbene analogs are 
easily synthesized using a single-step olefination reaction. 
Results: We have prepared a small 23-component 
hydroxystilbene library using a solid phase synthesis 
approach. The library was screened for estrogenic and 
antiestrogenic activity using a cell-based bioassay that mea- 
sures estrogen receptor-mediated transcription of a reporter 
gene.Three of the analogs proved to have dose-dependent 
estrogenic activity with EC,, values between 5 uM and 15 
/.&I. Further characterization of the hydroxystilbene-medi- 
ated estrogenic activity suggests that the agonist activity 
results from direct binding to the steroid site on the estro- 
gen receptor with IC,, values of l-10 PM. 
Conclusions: The results of this study show that classic 
olefination chemistry can be adapted to a solid-phase 
format for parallel synthesis of analog libraries. Although 
yields varied for the individual analogs, sufficient quantity of 
pure material was obtained directly h-om the resin for struc- 
tural characterization and biological evaluation. This study 
further validates solid-phase organic synthesis as a useful 
approach for rapid parallel-manifold library synthesis to 
augment both lead compound discovery and optimization. 
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Introduction 
Estrogen (17p-estradiol, Fig. la) is an important 
hormone that mediates a wide variety of cellular 
responses [l-4]. The biological responses triggered by 
estrogen are brought about by binding of the hormone 
to a specific nuclear estrogen receptor (ER). The 
hormone-bound ER forms an active dimer that func- 
tions as a transcription factor which mediates biological 
response by binding to specific promoter elements of 
DNA to initiate gene transcription (Fig. lb). Compounds 
that either induce or inhibit cellular estrogen responses 
are important biochemical tools and potential candidates 
for drug development. Estrogens are used in hormone 
replacement therapy for postmenopausal women, and the 
estrogen antagonist tamoxifen (Fig. la) is currently used 
for the treatment of breast cancer. In addition to having 
antagonist properties, tamoxifen also behaves as a partial 
ER agonist and this property has been suggested to be 
responsible for the drug resistance and endometrial 
cancer that some patients develop after prolonged 
tamoxifen treatment [5-71. 
A growing number of non-steroidal natural and synthetic 
aromatic compounds have been shown to possess estro- 
genie activity [8-121. Plant flavonoids including genistein 
and coumestrol, and synthetic compounds such as 
phenolphthalein, alkylphenols, and dihydroxystilbenes, 
have been shown to be moderate to strong agonists of the 
ER.There is currently much debate over the health risks 
associated with estrogenic activity of compounds that 
are either present in the environment, or used as 
pharmaceuticals, pesticides, and herbicides [13,14]. 
We have initiated a research effort aimed at studying the 
activity of a series of non-steroidal estrogenic com- 
pounds to gain insight into the various molecular mech- 
anisms of the estrogen response. The hydroxystilbene 
structure (Fig. la) was attractive as a starting point 
because similar hydroxylated aromatics are known to 
possess estrogenic activity [8], and because the synthesis 
of this structure is amenable to a manifold solid-phase 
approach allowing for rapid, parallel synthesis of a collec- 
tion of analogs.This technique has enjoyed great success 
in the synthesis of large peptide libraries [15], and recent 
published work from the laboratories of Ellman [16,17], 
Hobbs-Dewitt [18], Kurth [19,20], and Zuckerman [21] 
suggests that solid-phase organic synthesis will be useful 
for creating non-peptide libraries as well. 
R&Its 
Solid-phase library synthesis 
A 6 x 4 combinatorial matrix strategy was used to 
synthesize a small library of hydroxystilbenes on a 
polystyrene solid support using Horner-Emmons 
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Fig. 1. Activation and inhibition of estrogen receptor signaling. 
(a) Compounds that bind to and mediate the activity of the 
estrogen receptor. Estradiol is the natural ligand, ICI 164384 
is a potent antagonist, and tamoxifen has both agonist and 
antagonist activities. The agonist effects of hydroxystilbene 
derivatives are examined in this study. (b) Schematic of estrogen 
receptor activation. When estrogen (E) binds to the estrogen 
receptor (ER), the receptor can dimerize and bind to the 
estrogen response element (ERE), activating transcription of an 
estrogen-responsive gene. 
olefination chemistry (Fig. 2). Four different hydroxy- 
benzaldehydes were esterified with the acid-cleavable 
[4-(hydroxymethyl)phenoxy]acetic acid linker and 
attached to polystyreneaminomethyl (PAM) resin fol- 
lowing the strategy developed by Ellman and coworkers 
[16]. At this stage, each hydroxybenzaldehyde- 
derivatized resin sample was split into six aliquots, and 
each aliquot was treated in parallel with a solution of 
one of six different benzylphosphonate anions (Fig. 2). 
After washing away the unreacted phosphonate and 
phosphate biproduct, the hydroxystilbenes were cleaved 
from the resin by treatment with trifluoroacetic acid 
(TFA) and filtered through silica. Only one of the 
reactions failed to produce any detectable hydroxy- 
stilbene product (4-fluorobenzyl phosphonate with 
resin bound 3-hydroxy-4 methoxybenzaldehyde) so that 
twenty-three different hydroxystilbene derivatives were 
generated by this procedure (Table 1). Further purifica- 
tion of the compounds proved to be unnecessary as 
judged by thin layer chromatography (TLC), NMR 
spectroscopy, and mass spectrometry.The chemical yields 
for these solid-phase syntheses ranged from excellent 
(85 %) to poor (7 %) and no optimization of the indi- 
vidual yields was attempted. We did not observe 
unreacted hydroxybenzaldehyde starting material in any 
of the resin-cleaved hydroxystilbene products. Polar 
baseline material was observed in the TLC of the low 
yielding reactions and was presumed to be intractable 
polymer which was removed in the silica gel filtration. 
It was not determined whether this material was formed 
in the oletination reaction or in the subsequent acid- 
catalyzed linker cleavage reaction. However, sufficient 
quantity of each compound (2 5 mg) was obtained by 
this method for structural characterization, screening, 
and further biological evaluation. 
Estrogenic activity screens 
The library of hydroxystilbene derivatives was screened 
for estrogenic activity in a cell-culture assay that relies 
on the ability of ligand-activated ER to bind an 
I TFA 
Fig. 2. Synthetic scheme for the solid phase synthesis of 
hydroxystilbene analogs. Four different hydroxybenzaldehydes 
were attached to resin following the strategy developed by 
Ellman and coworkers [I 61, then treated with a solution of one 
of six different benzylphosphonate anions. The resulting 
hydroxystilbenes were cleaved from the resin by treatment with 
trifluoroacetic acid (TFA) and filtered through silica. 
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Table 1. Hydroxystilbene analog library. 
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*Yields based on resin-bound hydroxybenzaldehyde starting material as the limiting reagent. 
estrogen response element and drive the production of 
chloramphenicol acetyl transferase (CAT) from a 
reporter gene [22]. After transient transfection with 
reporter genes, each hydroxystilbene was added to 
cultured ERCl cells [22,23], a derivative of Chinese 
hamster ovary (CHO) cells that express human estrogen 
receptors, at a concentration of 50 PM. ER-regulated 
response was compared either to treatment with 17p- 
estradiol as a calibration standard or to treatment with 
an ethanolic vehicle. Hydroxystilbene series 1, 2, and 3 
showed no measurable estrogenic activity (data not 
shown), whereas series 4 compounds showed weak 
estrogenic activity (Fig. 3). Of the series 4 compounds, 
4A, 4E, and 4F were found to provide the highest levels 
of estrogenic activity relative to 17P-estradiol. 
To examine whether the series 4 compounds induce 
estrogenic activity through the ER, we tested the ability 
of the potent antiestrogen ICI 164384 (Fig. la) to inhibit 
the series 4 estrogenic activity. The ICI 164384 
compound was found to inhibit the estrogenic activity 
of all the series 4 compounds (Fig. 3). As a negative 
control, CHO cells, which lack functioning ER, were 
transfected with the same estrogen-responsive reporter 
constructs and treated with 17P-estradiol and the series 4 
hydroxystilbenes. As expected, no estrogenic activity was 
seen with these cells. 
Dose response and ER binding of series 4 
Dose response experiments were performed on the series 
4 compounds over a concentration range of O-100 PM 
(Fig. 4). For the most active compounds, 4A, 4E, and 4F, 
saturation is observed at 50 yM.The effective concentra- 
tion that provides 50 % maximum activity (EC,,) ranges 
from -5 PM to -15 PM for these three compounds. 
In vitvo ER binding assays were performed on the three 
most active series 4 compounds to confirm that the 
estrogenic activity measured in the bioassay correlated 
with binding affinity for the ER. The inactive 
hydroxystilbene analog 3D was included in the binding 
assay as a negative control. The ER-binding results for 
compounds 4A, 4E, and 4F are consistent with the 
estrogenic bioassay, as each of the compounds show IC,, 
values of l-10 PM for ER binding (Fig. 5). The two 
most active compounds in the bioassay, 4A and 4F, also 
show the highest affinity (1 PM) for the ER, although 
this affinity is approximately four orders of magnitude 
lower than that of 17P-estradiol.The analog 3D which 
showed no activity in the bioassay also shows no binding 
affinity for the ER. 
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Fig. 3. Weak estrogenic activity of series 4 compounds and 
inhibition by treatment with antiestrogen. Induction of CAT 
enzyme activity was measured after transfection of ERCl ceils 
with a reporter gene followed by treatment with series 4 com- 
pound alone (50 PM) or series 4 compound plus the antiestro- 
gen, ICI 164384 (1 ~.LM). Induction with 1 O-v M estradiol and 
ethanolic vehicle are shown as controls. Compounds 4A, 4E, 
and 4F appear most active although they are approximately 
four orders of magnitude less potent than estradiol. 
Discussion 
The new technology of combinatorial organic synthe- 
sis has the potential to dramatically expedite the dis- 
covery and optimization of lead compounds for drug 
discovery [24]. Because the central feature of this tech- 
nique involves organic synthesis on a solid support, the 
scope of combinatorial organic synthesis will hinge on 
the chemist’s ability to adapt classic solution-phase 
organic reactions to the solid phase. Examples of non- 
peptide organic compounds that have been prepared 
by solid-phase synthesis include benzodiazepines 
[16,181, hydantoins [18], (N-substituted)glycine 
oligomers [21], and p- mercaptoketones [20]. From the 
results presented here, hydroxystilbenes can now be 
added to this rapidly increasing list. For the hydroxy- 
stilbene solid-phase synthesis the final chemical yields 
of the resin-cleaved compounds ranged from excellent 
(85 %) to poor (7 %). However, the purity of the resin- 
cleaved compounds was uniformly high and the time 
required to produce the twenty-three compound 
library was significantly decreased because the resin- 
bound aldehydes could be sub-divided and taken 
through the olefination step in a parallel-manifold 
fashion, and because byproducts and excess reagents 
could be removed in a simple washing/filtration step. 
A fundamental difference between compounds like the 
hydroxystilbenes and biopolymers such as peptides 
(which are more easily adapted to solid-phase synthesis 
and combinatorial library generation) is that non-peptide 
compounds tend to have greater stability in viva, greater 
bioavailability, and greater cell-permeability. The assay 
used to screen estrogenic activity of the hydroxystilbene 
library is a cell-based bioassay where activity is predi- 
cated on the ability of the compound to accumulate in 
the nucleus of the cultured cells.The fact that several of 
the series 4 compounds showed estrogenic activity in this 
assay demonstrates that the stilbene core structure has the 
membrane permeability required for a non-steroidal 
estrogen. Moreover, the observation that activity was 
only seen for series 4 shows that this bioassay is able to 
discriminate active compounds from inactive compounds 
in the context of a lead compound screen. 
Additional experiments were performed to characterize 
further the estrogenic activity of the series 4 compounds 
identified in the initial screen. Four of the compounds 
(4A, 4B, 4E, and 4F) showed clear dose response profiles 
over a concentration range of O-100 PM (Fig. 4). The 
three most active compounds, 4A, 4E, and 4F, show 
maximum activity at 50 PM and have EC,, values for 
estrogen response in the range of 5-15 pM.Three lines of 
evidence suggest that the series 4 estrogenic response is 
mediated by direct binding of the hydroxystilbene to 
the estrogen binding site of the ER. First, the fact that 
no estrogenic activity was observed in reporter gene-trans- 
fected CHO cells which lack a functional ER 
provides evidence that the response to the series 4 com- 
pounds was ER-mediated. Second, the observation that 
the response initiated by all the series 4 compounds could 
be inhibited by ICI 164384, a potent steroidal antiestrogen 
that competes with 17P-estradiol for binding to the ER, 
provides evidence that the hydroxystilbenes act through 
direct binding to the steroid binding site on the ER. 
Third, the binding affinity of the series 4 compounds to 
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Fig. 4. Dose response curves for series 4. Dose response experi- 
ments were performed on the series 4 compounds over a con- 
centration range of O-l 00 PM. For the most active compounds, 
4A, 4E, and 4F, saturation is observed at 50 PM. The effective 
concentration that provides 50 % maximum activity (EC,,) 
ranges from -5 PM to -15 pM for these three compounds. 
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Fig. 5. ER binding/competition assay for 
compounds 4A, 4E, 4F, and 3D. In vitro 
ER binding assays were performed to 
confirm that the estrogenic activity 
measured in the bioassay correlated 
with binding affinity for the ER. The 
series 4 compounds show IC,,, values of 
I-IO FM for ER binding. Compound 
3D, which does not show biological 
activity, does not bind ER. 
60 - 
Concentration (M) 
the ER was directly measured in a competition binding 
assay with 17/%estradiol and the measured IC,, values for 
the series 4 hydroxystilbenes correlate approximately with 
the EC,, values measured horn the dose response bioassay. 
Structure-activity relationships (SAR) in both the 
hydroxy-substituted and distal aromatic rings of the 
hydroxystilbenes are evident from the varying estrogenic 
activities of the library. Based on the observation that 
activity was only seen in the series 4 compounds, it 
appears that a para orientation between the hydroxyl 
substituent and the stilbene olefin is a requirement for 
ER-binding and activation.The para orientation is sensi- 
tive to additional substitution as evidenced by the fact 
that no estrogenic activity was observed for the series 3 
(4-hydroxy-3-nitro) compounds; it is unclear whether 
steric or electronic factors are responsible for the lack of 
activity in series 3. For the series 4 compounds, the 
three most active hydrodxystilbenes bear either small flu- 
orine substituents (4E, 4F) or no substitution (4A) in 
the distal aromatic ring. This distal ring SAR is some- 
what subtle; based on the dose-response data (Fig. 4), the 
4’-Br substituted compound (4C) shows almost no 
activity, whereas the 4’-F substituted compound (4F) is 
the second most active member of the series. Here 
again, it is unclear whether steric effects, electronic 
effects, or a combination of both are responsible for the 
variations in estrogenic activity. 
Significance 
Advances in the field of combinatorial organic 
synthesis will depend on the adaptation of classic 
organic reactions to solid-phase synthesis. We have 
shown that the Hornet-Emmons olefination 
process, a classic C-C bond-forming reaction, can 
be adapted to a solid-phase format for the prepa- 
ration of hydroxystilbenes. Although substituent- 
dependent variation in chemical yield was 
observed in the preparation of a 23-component 
library, suffkient quantities of pure compounds 
were obtained without a purification step for 
structural characterization. Moreover, enough 
material was produced to screen each compound 
in a cell-based estrogenic assay, and to obtain 
more detailed characterization of the estrogenic 
activity of the positives identified from the screen. 
This functional characterization shows that three 
of the hydroxystilbene analogs permeate cell 
membranes and trigger a dose-dependent estro- 
genie response with EC,, values in the range of 
5-15 PM. Results from competition-response and 
ER-binding experiments with the antiestrogen 
ICI 164384 and 17P-estradiol provide evidence 
that the non-steroidal hydroxystilbene analogs 
elicit the estrogenic response through direct 
interaction with the steroid binding site of the 
estrogen receptor. In addition, structure-activity 
relationships for the hydroxystilbene pharma- 
cophore are evident from the activity profile of 
the library. Such information could prove useful 
for predicting potential estrogenic activity of 
environmental pollutants and pharmaceuticals. 
Materials and methods 
Synthesis 
The [4-(hydroxymethyl)phenoxy]acetic acid linker was 
attached to the hydroxybenzaldehydes and the resulting 
linker-derivatized aldehydes were attached to PAM resin 
according to the procedures of Ellman and colleagues [16]. 
The hydroxybenzaldehyde-derivatized resin was prepared on 
a 0.3-I .O mmol scale and subdivided into six equal portions 
by weight for parallel treatment with the six different ben- 
zylphosphonate anions.The anions were generated in separate 
flasks by treating 1.3 mmol of the benzylphosphonate (lo- 
fold molar excess over resin bound aldehyde) with 2.0 mmol 
sodium methoxide in 5 ml dimethyl formamide (DMF). After 
stirring the anion solution for 0.5 h at room temperature, a 
0.13 mmol portion of resin aldehyde was added and the 
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mixture was stirred at room temperature overnight. Six such 
reactions corresponding to the number of benzylphospho- 
nates were carried out in parallel.The reaction mixture was 
filtered and the resin was washed with (5 x 20 ml) of water, (5 
x 20 ml) DMF, (5 x 20 ml) I:1 DMF:water, and (5 x 20 ml) 
methylene chloride.The resin was then dried in vacua. 
The hydroxystilbene product was cleaved from the resin by 
treatment with IO ml of a 95:5 solution of trifluoroacetic acid 
in water. The resulting slurry was stirred for l-2 h at room 
temperature, then concentrated in vacua. The crude residue was 
dissolved in 10 ml of a 1:2 solution of methanol in methylene 
chloride, filtered through a plug of silica gel, and concentrated 
in vacua to provide the hydroxystilbene product in homo- 
genous form as judged by TLC, NMR spectroscopy, and mass 
spectrometry. The chemical yields for the hydroxystilbenes 
ranged from 7 to 85 % based on the amount of resin-bound 
hydroxyaldehyde starting material as the limiting reagent. 
Cell culture 
ERCl cells [22,23] and CHO cells were cultured in Coon’s 
F-12/Dulbecco’s Modified Eagle’s Medium (1:1) without 
phenol red (UCSF Cell Culture Facility) supplemented with 
10 % iron-supplemented low estrogen calf serum (Sigma, St. 
Louis, MO; batch 19F-0156). ERCI cells were supplemented 
with 50 PM zinc sulfate (Sigma, St. Louis, MO) and 40 FM 
cadmium sulfate (Sigma, St. Louis, MO) to maintain expression 
and selection of the ER gene. 
Electroporation and CAT assays 
Transfections and CAT assays were performed as described pre- 
viously [22,25].The expression vector (GL45),-CAT was made 
by ligating an oligonucleotide with Hind111 ends into the 
Hind111 site of pBL8. (pBL8 was a kind gift of G. Ryffel and 
contains a tk-CAT/SV40 fusion gene cloned into pEMBL8+ 
[26].) The GL45 oligo consisted of sequences -333/-288 of the 
vitellogenin A2 gene and was inserted in tandem with the 
second GL45 oligo. ERCl cells (CHO cells that 
stably express human ER at supraphysiologic levels) 
were transiently transfected with the reporter construct by elec- 
troporation.Transfection efficiency and treatment toxicity were 
monitored by co-transfecting 2 pg per cuvette of 
P-human chorionic gonadotrophin (hCG) reporter plasmid 
[27] which was assayed with a standard kit using iodinated anti- 
body (Tandem-R P-hCG Kit, Hybritech Inc., San Diego, CA). 
Cells from multiple transfections were pooled and plated into 
six well dishes (Co-Star) and ERCI cells were supplemented 
with 50 PM zinc sulfate. Cells were treated with stilbene 
derivative with or without ICI 164384 (1 FM) or estradiol at 
the concentrations indicated within 2 h, then assayed for CAT 
enzyme activity 24 to 48 h later using chloramphenicol 
and 8 mCi ml-’ tritiated acetyl Coenzyme-A (DuPont, 
Wilmington, DE) as previously described [22,25]. CAT 
enzyme activity was corrected to background and P-hCG 
counts were used as a measure of treatment toxicity A single 
experiment representative of several independent experiments 
is presented. The data shown indicate the mean and standard 
deviation of duplicate estimations. 
Estradiol competition ER-binding assay 
MCF7 cells were grown as monolayer cultures in phenol red- 
free RPMI-1640 medium with 5 % charcoal-treated fetal 
bovine serum fortified with 0.2 ng ml-’ insulin (CT-FR). For 
experiments, cells were removed from their growth chamber 
with trypsin/EDTA, diluted in 1 % CT-FR to 1.75 (+ 0.5) x 
IO6 cells ml-’ and 100 l,~l were incubated with 50 ~1 of 
0.4 nM 1251-estradiol (2200 Ci mmol-‘, NEN DuPont) in 
1 % CT-FR and 50 ~1 of the hydroxystilbenes in 1 % CT-FR 
(prepared in ethanol as 1000x stock solutions and diluted 
250-fold in 1 % CT-FR). Control samples contained 1 % 
CT-FR with 0.4 % ethanol. Cells were incubated at 37 “C 
with 5 % CO, for 45 min with gentle mixing every 15 min. 
Following incubation, nuclei were prepared by lysing cells 
with 1 ml of ice-cold TPSG (0.2 % Triton X-100 in PBS 
containing 0.1 M sucrose and 10 % glycerol) as previously 
described [28]. The 1251-estradiol in the nuclear pellet was 
measured in a gamma counter and the results are expressed as 
per cent ‘251-estradiol binding to ER in the nucleus in the 
absence (control = 100 %) and presence of increasing con- 
centrations of the hydroxystilbene test compounds. 
Supplementary material available 
Physicochemical data for the linker-derivatized hydroxy- 
benzaldehydes and hydroxystilbene compounds. 
Acknowledgements: This work was supported by grant 
2-519977-38890 from the University of California Cancer 
Research Coordinating Committee (T.S.S.), by grant #BE- 
61E from the American Cancer Society (PJ.K.), by the UCSF 
NIH Biotechnology Training Grant GM-08388 (R.W.), and by 
a fellowship from the American Foundation for 
Pharmaceutical Education (R.W.). Mass spectral analysis of 
synthetic compounds was provided by the UCSF Mass 
Spectrometry Facility (A.L. Burlingame, Director) supported 
by the Biomedical Research Technology Program of the 
National Center for Research Resources, NIH NCRR 
BRTP01614 and NIH NIEHS ES04705. 
References 
1. 
2. 
3. 
0. 
9. 
10. 
11. 
12. 
13. 
14. 
Cronemeyer, H. (1993). Transcription activation by nuclear 
receptors. /. Recept. Res. 13,667-91. 
O’Malley, B.W. & Tsai, M.J. (1992). Molecular pathways of steroid 
receptor action. Biol. Reprod. 46, 163-7. 
O’Malley, B.W., Tsai, S.Y., Bagchi, M., Weigel, N.L., Schrader, W.T. 
& Tsai, M.J. (1991). Molecular mechanism of action of a steroid 
hormone receptor. Recent. Prog. Harm. Res. 47, l-26. 
Jensen, E.V. (1991). Steroid hormone receptors. Curr. Top. Who/. 
83,365-431. 
Horwitz, K.B. (1994). How do breast cancers become hormone 
resistant? J. Steroid Biochem. Mol. Biol. 49, 295-302. 
Horwitz, K.B. (1993). Mechanisms of hormone resistance in breast 
cancer. Breast Cancer Res. Treat. 26, 119-30. 
Wiebe, V.I., Osborne, C.K., Fuqua, S.A. & DeGregorio, M.W. 
(1993). Tamoxifen resistance in breast cancer. Crit. Rev. Oncol. 
Hematol. 14, 173-88. 
Miksicek, R.J. (1993). Commonly occurring plant flavonoids have 
estrogenic activity. Mol. Pharmacol. 44, 37-43. 
Nieto, A., Garcia, C. & DeHaro, M.S.L. (1990). In vivo estrogenic 
and antiestrogenic activity of phenolphthalein and derivative 
compounds. Biochem. Int 21, 305-311. 
White, R., Jobling, S., Hoare, S.A., Sumpter, J.P. & Parker, M.C. 
(1994). Environmentally persistent alkylphenolic compounds are 
estrogenic. Endocrinology 135, 175-l 82. 
Makela, S., et al., & Korach, K.S. (1994). Dietary estrogens act 
through estrogen receptor-mediated processes and show no 
antiestrogenicitv in cultured breast cancer cells. Environ. Health 
Perspect.182, 572-578. 
Krishnan, A.V., Stathis, P., Permuth, S.F., Tokes, L. & Feldman, D. 
(1993). Bisphenol-A: an estrogenic substance is released from 
polycarbonate flasks during autoclaving. Endocrinology 132, -, 
2279-2286. 
Stone, R. (1994). Environmental estrogens stir debate. Science 265, 
308-310. 
Colborn, T., vom Saal, F.S. & Soto, A.M. (1993). Developmental 
effects of endocrine-disrupting chemicals in wildlife and humans. 
Synthesis of a hydroxystilbene library Wi I I iard et a/. 51 
15. 
16. 
17. 
18. 
19. 
20. 
21. 
22. 
Environ. Health Perspect. 101, 378-384. 
Gallop, M.A., Barrett, R.W., Dower, W.J., Fodor, S.P.A. & Gordon, 
E.M. (1994). Applications of combinatorial technologies to drug 
discovery. 1. Background and peptide combinatorial libraries. /. 
Med. Chem. 37, 1233-1251. 
Bunin, B.A. & Ellman, J.A. (1992). A general and expedient method 
for the solid-phase synthesis of 1,4-benzodiazepine derivatives. /. 
Am. Chem. Sot. 114, 10997-l 0998. 
Bunin, B.A., Plunkett, M.J. & Ellman, ].A. (1994). The combinatorial 
synthesis and chemical and biological evaluation of a 1,4-benzodi- 
azepine library. Proc. Nat/. Acad. Sci. USA 91, 4708-4712. 
Hobbs-Dewitt, S., Kiely, J.S., Stankovic, C.J., Schroeder, M.C., 
Reynolds Cody, D.M. & Pavia, M.R. (1993). ‘Diversomers’: an 
approach to nonpeptide, nonoligomeric chemical diversity. Proc. 
Nat/. Acad. Sci. USA 90, 6909-6913. 
Beebe, X., Schore, N.E. & Kurth, M.J. (1992). Polymer-supported 
synthesis of 2,5-disubstituted tetrahydrofurans. /. Am. Chem. Sot. 
114, 10061-10062. 
Chen, C., Ahlberg Randall, L.A., Miller, R.B., Jones, A.D. & Kurth, 
M.J. (1994). ‘Analogous’ organic synthesis of small-compound 
libraries: validation of combinatorial chemistry in small-molecule 
synthesis. /. Am. Chem. Sot. 116, 2661-2662. 
Zuckerman, R.N., et al., & Moos, W.H. (1994). Discovery of 
nanomolar ligands for 7-transmembrane G-protein coupled 
receptors from a diverse (N-substituted)glycine peptoid library. /. 
Med. Chem. 37,267%-2685. 
Webb, P., Lopez, G.N., Greene, C.L., Baxter, J.D. & Kushner, P.J. 
(1992). The limits of the Icellular capacity to mediate the estrogen 
23. 
24. 
25. 
26. 
27. 
28. 
response. Mol. Endocrinol. 6, 157-l 67. 
Kushner, P.J., Hort, E., Shine, J., Baxter, J.D. & Greene, C.L. (1990). 
Construction of cell lines that express high levels of the human 
estrogen receptor and are killed by estrogens. Mol. Endocrinol. 4, 
1465-73. 
Gordon, E.M., Barrett, R.W., Dower, W.J., Fodor, S.P.A. & Gallop, 
M.A. (1994). Applications of combinatorial technologies to drug 
discovery. 2. Combinatorial organic synthesis, library screening 
strategies, and future directions. /. Med. Chem. 37, 1385-1401. 
Sadovsky, Y., Kushner, P.J., Roberts, J.M. & Riemer, R.K. (1993). 
Restoration of estrogen-dependent progesterone receptor expression 
in a uterine myocyte cell line. Endocrinology 132, 1609-l 613. 
Klein-Hitpass, L., Schorpp, M., Wagner, U. & Ryffel, G.U. (1986). 
An estrogen-responsive element derived from the 5’ flanking region 
of the Xenopus vitellogenin A2 gene functions in transfected human 
cells. Cell 46, 1053-l 061. 
Lopez, G., Schaufele, F., Webb, P., Holloway, J.M., Baxter, J.D. & 
Kushner, P.J. (1993). Positive and negative modulation of Jun action 
by thyroid hormone receptor at a unique APl site. Mol. Cell. Biol. 
13, 3042-3049. 
DiLorenzo, D., Albertini, A. & Zava, D.T. (1991). Progestin 
regulation of alkaline phosphatase in the human breast cancer cell 
line T47D. Cancer Res. 51.44704475. 
Received: 12 Dee 1994; revisions requested: 22 Dee 1994; 
revisions received: 29 Dee 1994. Accepted: 29 Dee 1994. 
